Condition
Developmental Delay Disorders
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02359084Not ApplicableCompleted
Project EARLY: Engagement, Assessment, Referral, & Linkage for Young Children
NCT00088426Completed
Clinical and Genetic Studies on Holoprosencephaly
NCT00506259Phase 1CompletedPrimary
Treatment Strategies for Children With Smith-Magenis Syndrome
NCT00234247Completed
Prolonged Outcomes After Nitric Oxide (PrONOx)
NCT00754897Completed
Feasibility Study for PANDAS
Showing all 5 trials